Clinical trial

Analysis of Hydrocodone Compared to Acetaminophen and Ibuprofen for Post-nail Procedure Analgesia

Name
21-10024054
Description
The purpose of this study is to assess the safety and efficacy of ropivacaine and hydrocodone for nail-procedure associated pain management. The investigators hypothesize that ropivacaine with hydrocodone will be superior to ropivacaine with acetaminophen and ibuprofen for managing pain.
Trial arms
Trial start
2022-11-10
Estimated PCD
2023-05-15
Trial end
2023-06-01
Status
Completed
Phase
Early phase I
Treatment
Hydrocodone 5Mg/Acetaminophen 325Mg Tab
5 mg/325 mg tablet
Arms:
Hydrocodone 5mg/acetaminophen 325mg
Other names:
Vicodin, Norco, Lortab
Acetaminophen 1000mg
1000 mg tablet
Arms:
Acetaminophen 1000mg + Ibuprofen 400mg, Hydrocodone 5mg/acetaminophen 325mg
Other names:
Tylenol
Ibuprofen 400 mg
400 mg tablet
Arms:
Acetaminophen 1000mg + Ibuprofen 400mg, Hydrocodone 5mg/acetaminophen 325mg
Other names:
Advil, Motrin
Size
20
Primary endpoint
Change From Baseline in Pain Scores on Postoperative Day 2, as Measured by the Wong-Baker 0-to-10 Pain Scale
Baseline, 2 days
Eligibility criteria
Inclusion Criteria: * Patients undergoing fingernail or toenail, excision, or shave biopsy * Must understand and voluntarily sign an informed consent form * Must be male or female and aged 18-95 years at time of consent * Must be able to adhere to the study visit schedule and other protocol requirements Exclusion Criteria: * Subject is unable to provide written informed consent for any reason * Subject has peripheral vascular disease, arterial insufficiency, peripheral neuropathy * Subject is on Aspirin, NSAIDs, or consumes a chronic medication for control of any other chronic pain * Subject has a history of opioid or alcohol use disorder * Subject has a history of peptic ulcer disease, gastritis, chronic renal insufficiency or a history of kidney disease, or has underlying liver disease * Subject has a history of severe constipation * Subject is sensitive or allergic to any of the elements included in this study * Subject is unable to complete the required pain dairy * Subject is pregnant, planning pregnancy, or nursing
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 20, 'type': 'ACTUAL'}}
Updated at
2023-09-28

1 organization

3 products

2 indications

Indication
Nail Diseases
Product
Ibuprofen